On the other hand, it is also suggested that the downregulation of the IGF-1 (insulin-like growth factor 1) and GLP-1 (glucagon-like peptide-1) signaling pathways significantly affects the progression of ALS pathogenesis [5]. The gene discussed is GCG; the disease is amyotrophic lateral sclerosis.